330 related articles for article (PubMed ID: 26981525)
1. Substance P Receptor Signaling Mediates Doxorubicin-Induced Cardiomyocyte Apoptosis and Triple-Negative Breast Cancer Chemoresistance.
Robinson P; Kasembeli M; Bharadwaj U; Engineer N; Eckols KT; Tweardy DJ
Biomed Res Int; 2016; 2016():1959270. PubMed ID: 26981525
[TBL] [Abstract][Full Text] [Related]
2. Beet root juice protects against doxorubicin toxicity in cardiomyocytes while enhancing apoptosis in breast cancer cells.
Das S; Filippone SM; Williams DS; Das A; Kukreja RC
Mol Cell Biochem; 2016 Oct; 421(1-2):89-101. PubMed ID: 27565811
[TBL] [Abstract][Full Text] [Related]
3. Protective effects of deep sea water against doxorubicin‑induced cardiotoxicity in H9c2 cardiac muscle cells.
Lee DH; Kim S; Nam KS
Int J Oncol; 2014 Dec; 45(6):2569-75. PubMed ID: 25270851
[TBL] [Abstract][Full Text] [Related]
4. Enhanced-autophagy by exenatide mitigates doxorubicin-induced cardiotoxicity.
Lee KH; Cho H; Lee S; Woo JS; Cho BH; Kang JH; Jeong YM; Cheng XW; Kim W
Int J Cardiol; 2017 Apr; 232():40-47. PubMed ID: 28159361
[TBL] [Abstract][Full Text] [Related]
5. Naringin protects myocardial cells from doxorubicin‑induced apoptosis partially by inhibiting the p38MAPK pathway.
Jian CY; Ouyang HB; Xiang XH; Chen JL; Li YX; Zhou X; Wang JY; Yang Y; Zhong EY; Huang WH; Zhang HW
Mol Med Rep; 2017 Dec; 16(6):9457-9463. PubMed ID: 29152646
[TBL] [Abstract][Full Text] [Related]
6. Doxorubicin-polyglycerol-nanodiamond conjugate is a cytostatic agent that evades chemoresistance and reverses cancer-induced immunosuppression in triple-negative breast cancer.
Yuan SJ; Xu YH; Wang C; An HC; Xu HZ; Li K; Komatsu N; Zhao L; Chen X
J Nanobiotechnology; 2019 Oct; 17(1):110. PubMed ID: 31623629
[TBL] [Abstract][Full Text] [Related]
7. Stat3/Oct-4/c-Myc signal circuit for regulating stemness-mediated doxorubicin resistance of triple-negative breast cancer cells and inhibitory effects of WP1066.
Cheng CC; Shi LH; Wang XJ; Wang SX; Wan XQ; Liu SR; Wang YF; Lu Z; Wang LH; Ding Y
Int J Oncol; 2018 Jul; 53(1):339-348. PubMed ID: 29750424
[TBL] [Abstract][Full Text] [Related]
8. GPR91 Receptor Mediates Protection against Doxorubicin-Induced Cardiotoxicity without Altering Its Anticancer Efficacy. An In Vitro Study on H9C2 Cardiomyoblasts and Breast Cancer-Derived MCF-7 Cells.
Dallons M; Alpan E; Schepkens C; Tagliatti V; Colet JM
Cells; 2020 Sep; 9(10):. PubMed ID: 32992522
[TBL] [Abstract][Full Text] [Related]
9. Hydrogen sulfide attenuates doxorubicin-induced cardiotoxicity by inhibition of the p38 MAPK pathway in H9c2 cells.
Guo R; Lin J; Xu W; Shen N; Mo L; Zhang C; Feng J
Int J Mol Med; 2013 Mar; 31(3):644-50. PubMed ID: 23338126
[TBL] [Abstract][Full Text] [Related]
10. Protective Role of GPER Agonist G-1 on Cardiotoxicity Induced by Doxorubicin.
De Francesco EM; Rocca C; Scavello F; Amelio D; Pasqua T; Rigiracciolo DC; Scarpelli A; Avino S; Cirillo F; Amodio N; Cerra MC; Maggiolini M; Angelone T
J Cell Physiol; 2017 Jul; 232(7):1640-1649. PubMed ID: 27607345
[TBL] [Abstract][Full Text] [Related]
11. Identification of a novel mechanism for reversal of doxorubicin-induced chemotherapy resistance by TXNIP in triple-negative breast cancer via promoting reactive oxygen-mediated DNA damage.
Chen Y; Feng X; Yuan Y; Jiang J; Zhang P; Zhang B
Cell Death Dis; 2022 Apr; 13(4):338. PubMed ID: 35414060
[TBL] [Abstract][Full Text] [Related]
12. p-Coumaric acid mediated protection of H9c2 cells from Doxorubicin-induced cardiotoxicity: Involvement of augmented Nrf2 and autophagy.
Sunitha MC; Dhanyakrishnan R; PrakashKumar B; Nevin KG
Biomed Pharmacother; 2018 Jun; 102():823-832. PubMed ID: 29605770
[TBL] [Abstract][Full Text] [Related]
13. Effects of Ganoderma lucidum polysaccharides against doxorubicin-induced cardiotoxicity.
Xu F; Li X; Xiao X; Liu LF; Zhang L; Lin PP; Zhang SL; Li QS
Biomed Pharmacother; 2017 Nov; 95():504-512. PubMed ID: 28866417
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of cyclin-dependent kinase 2 protects against doxorubicin-induced cardiomyocyte apoptosis and cardiomyopathy.
Xia P; Liu Y; Chen J; Coates S; Liu DX; Cheng Z
J Biol Chem; 2018 Dec; 293(51):19672-19685. PubMed ID: 30361442
[TBL] [Abstract][Full Text] [Related]
15. Cancer-associated fibroblasts induce high mobility group box 1 and contribute to resistance to doxorubicin in breast cancer cells.
Amornsupak K; Insawang T; Thuwajit P; O-Charoenrat P; Eccles SA; Thuwajit C
BMC Cancer; 2014 Dec; 14():955. PubMed ID: 25512109
[TBL] [Abstract][Full Text] [Related]
16. Influence of doxorubicin on apoptosis and oxidative stress in breast cancer cell lines.
Pilco-Ferreto N; Calaf GM
Int J Oncol; 2016 Aug; 49(2):753-62. PubMed ID: 27278553
[TBL] [Abstract][Full Text] [Related]
17. Induction of P-glycoprotein expression by dandelion in tumor and heart tissues: Impact on the anti-tumor activity and cardiotoxicity of doxorubicin.
Qu J; Ke F; Yang X; Wang Y; Xu H; Li Q; Bi K
Phytomedicine; 2022 Sep; 104():154275. PubMed ID: 35760022
[TBL] [Abstract][Full Text] [Related]
18. Foxo3a inhibits mitochondrial fission and protects against doxorubicin-induced cardiotoxicity by suppressing MIEF2.
Zhou L; Li R; Liu C; Sun T; Htet Aung LH; Chen C; Gao J; Zhao Y; Wang K
Free Radic Biol Med; 2017 Mar; 104():360-370. PubMed ID: 28137654
[TBL] [Abstract][Full Text] [Related]
19. Thrombopoietin protects against in vitro and in vivo cardiotoxicity induced by doxorubicin.
Li K; Sung RY; Huang WZ; Yang M; Pong NH; Lee SM; Chan WY; Zhao H; To MY; Fok TF; Li CK; Wong YO; Ng PC
Circulation; 2006 May; 113(18):2211-20. PubMed ID: 16651473
[TBL] [Abstract][Full Text] [Related]
20. Reactive oxygen species-independent apoptosis in doxorubicin-treated H9c2 cardiomyocytes: role for heme oxygenase-1 down-modulation.
Bernuzzi F; Recalcati S; Alberghini A; Cairo G
Chem Biol Interact; 2009 Jan; 177(1):12-20. PubMed ID: 18845130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
